BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 15199544)

  • 1. Studies with the azoxymethane-rat preclinical model for assessing colon tumor development and chemoprevention.
    Reddy BS
    Environ Mol Mutagen; 2004; 44(1):26-35. PubMed ID: 15199544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel approaches for colon cancer prevention by cyclooxygenase-2 inhibitors.
    Reddy BS; Rao CV
    J Environ Pathol Toxicol Oncol; 2002; 21(2):155-64. PubMed ID: 12086402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
    Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
    Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.
    Jacoby RF; Cole CE; Tutsch K; Newton MA; Kelloff G; Hawk ET; Lubet RA
    Cancer Res; 2000 Apr; 60(7):1864-70. PubMed ID: 10766173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of colon cancer by low doses of celecoxib, a cyclooxygenase inhibitor, administered in diet rich in omega-3 polyunsaturated fatty acids.
    Reddy BS; Patlolla JM; Simi B; Wang SH; Rao CV
    Cancer Res; 2005 Sep; 65(17):8022-7. PubMed ID: 16140976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention of colorectal cancer.
    Gwyn K; Sinicrope FA
    Am J Gastroenterol; 2002 Jan; 97(1):13-21. PubMed ID: 11808936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of NSAIDs for the chemoprevention of colorectal cancer.
    Herendeen JM; Lindley C
    Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity.
    Rao CV; Wang CQ; Simi B; Rodriguez JG; Cooma I; El-Bayoumy K; Reddy BS
    Cancer Res; 2001 May; 61(9):3647-52. PubMed ID: 11325834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
    Sandler RS
    Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chemopreventive agents on intermediate biomarkers during different stages of azoxymethane-induced colon carcinogenesis.
    Singh J; Kelloff G; Reddy BS
    Cancer Epidemiol Biomarkers Prev; 1992; 1(5):405-11. PubMed ID: 1305473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat.
    Wargovich MJ; Chen CD; Jimenez A; Steele VE; Velasco M; Stephens LC; Price R; Gray K; Kelloff GJ
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):355-60. PubMed ID: 9162301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a combination of docosahexaenoic acid and 1,4-phenylene bis(methylene) selenocyanate on cyclooxygenase 2, inducible nitric oxide synthase and beta-catenin pathways in colon cancer cells.
    Narayanan BA; Narayanan NK; Desai D; Pittman B; Reddy BS
    Carcinogenesis; 2004 Dec; 25(12):2443-9. PubMed ID: 15297372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
    Moyad MA
    Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention.
    Kashfi K; Rigas B
    Biochem Pharmacol; 2005 Oct; 70(7):969-86. PubMed ID: 15949789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cyclooxygenase-2 in primary superficial bladder cancer tissue may predict risk of its recurrence after complete transurethral resection.
    Okajima E; Uemura H; Ohnishi S; Tanaka M; Ohta M; Tani M; Fujimoto K; Ozono S; Okajima E; Hirao Y
    Aktuelle Urol; 2003 Jul; 34(4):256-8. PubMed ID: 14566678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-steroidal anti-inflammatory drugs and chemoprevention of digestive cancer].
    Wei WQ; Qiao YL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Feb; 23(1):78-82. PubMed ID: 12905826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.
    Cook JC; Jacobson CF; Gao F; Tassinari MS; Hurtt ME; DeSesso JM
    Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):5-26. PubMed ID: 12852480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention of colorectal cancer.
    Das D; Arber N; Jankowski JA
    Digestion; 2007; 76(1):51-67. PubMed ID: 17947819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprevention of gastrointestinal malignancies with nonsteroidal antiinflammatory drugs.
    Shaheen NJ; Straus WL; Sandler RS
    Cancer; 2002 Feb; 94(4):950-63. PubMed ID: 11920463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.